Dynamic LVOT Obstruction

• Recent literature has indicated that dynamic LVOT obstruction can occur in critically ill patients without hypertrophic cardiomyopathy. In fact, a recent study found that this condition may be present in many patients with septic shock.
• Risk factors for  LVOT obstruction include any condition that decreases afterload, decreases preload, or increases heart rate.
• Consider LVOT obstruction when your ultrasound demonstrates close approximation of the lateral wall and septum plus systolic anterior motion of the anterior mitral leaflet.
• The treatment of patients with dynamic LVOT obstruction includes:
  • Increasing preload with aggressive IVFs
  • Increasing afterload (phenylephrine may be a good choice)
  • Avoiding inotropes
  • Decreasing heart rate (often with esmolol)

Show References

Oxygen-ICU Trial

• Recent observational trials have demonstrated an association between hyperoxia and worse outcomes in select critically ill patient populations.
• The Oxygen-ICU Trial was just published online in JAMA, and was an RCT to assess whether a conservative protocol for oxygen supplementation could improve outcomes in critically ill ICU patients compared with usual care.
• A total of 236 patients were randomized to the conservative oxgyen group (PaO2 target 70-100 mm Hg, SpO2 94-98%), whereas 244 were randomized to the usual care group (PaO2 up to 150 mm Hg, SpO2 97-100%).
• The results demonstrated that ICU mortality was lower in patients treated witih a conservative oxygen strategy, with an absolute risk reduction of 8.6%.
• Take Home Point: Be careful with the tiration of oxygen therapy and avoid hyperoxia in many of your critically ill patients.

Show Additional Information

Show References

Pitfalls with PLR

• The passive leg raise (PLR) test has become a popular method to assess volume responsiveness in critically ill patients.
• PLR mobilizes a volume of approximately 150-300 mL and can be used in spontaneously breathing patients, those receiving positive pressure ventilation, or those with various arrhythmias. 
• In order to properly perform the PLR, you must have a method to monitor cardiac output. (See previously pearl on 7/26/16).
• Pitfall: Simply monitoring arterial blood pressure alone is not a sufficient method to assess a positive PLR.
• Pitfalls:Risks of performing a PLR include increased intracranial pressure, reduced cerebral blood flow, and decreased pulmonary compliance.

Show References

Ketamine for RSE?

• Up to 43% of patients with status epilepticus may progress to refractory status epilepticus (RSE).
• Propofol, midazolam, and barbituates are often recommended for patients with RSE.
• Importantly, all of these medications may be limited by hypotension and respiratory depression.
• Ketamine is emerging as adjuvant therapy for patients with RSE.
• The loading dose of ketamine ranges from 0.5 to 3 mg/kg, followed by a maintenance infusion of 0.3 to 4 mg/kg/h.

Show References

Zika Virus-associated GBS

• Zika virus has been shown to trigger Guillain-Barre Syndrome (GBS) at a rate similar to Campylobacter jejuni infections.
• In patients with Zika virus-associated GBS, neurologic deterioration has been rapid, with approximately 33% of patients developing respiratory distress.
• For patients who have required intubation, the duration of mechanical ventilation and length of ICU stay has been very long.
• Consider Zika virus-associated GBS in patients with muscle weakness, facial palsy, or paresthesias in the setting of a travel or exposure history to the virus.

Show References

Predicting Fluid Responsiveness with ETCO2

• It is well known that almost 50% of critically ill patients do not respond to fluid resuscitaiton. For those that do not respond, indiscriminate fluid administration may be harmful.
• There is increasing emphasis on the use of dynamic markers of fluid responsiveness, namely passive leg raise (PLR), pulse pressure variation, respirophasic changes in the IVC, and many others.
• ETCO2 can also be used to assess fluid responsiveness in mechanically ventilated patients with no spontaneous respiratory effort.
• An increase in ETCO2 of at least 5% with a PLR has been shown to outperform arterial pulse pressure as a measure of fluid responsiveness.

Show References

Show References

LVADs and RV Failure

• Acute RV failure can be seen in up to 10% of patients after LVAD implantation.
• The treatment of RV failure in the LVAD patient consists of the following:
  • Fluids: avoid aggressive fluid administration, as this can displace the septum and impair LVAD function
  • Inotropes: consider early initiation of dobutamine, milrinone, or epinephrine to augment RV function
  • Vasopressors: target a MAP higher than 60 to 70 mmHg to maintain RV perfusion pressure
• If intubated, avoid hypoxia, hypercarbia, high PEEP, and high ventilator pressures.  These can increase pulmonary vascular resistance and further worsen RV function.

Show References

Heat Stroke

• Heat stroke is critical illness defined as a core body temperature greater than or equal to 40^oC and altered level of consciousness.
• Mortality from heat stroke can be as high as 30%.
• Numerous methods exist to rapidly cool patients below 39^oC.
• Of these methods, ice-water immersion cools patients the fastest and is highly effective in young patients with exertional heat stroke.
• There is currently insufficient evidence to routinely recommend antipyretic agents, intravascular cooling devices, body cavity lavage, or the use of ice packs in the groin/axilla/neck. In addition, dantrolene is not recommended in the treatment of heat stroke.

Show References

Situations Where ECMO Will Likely Fail

• As many EDs and ICUs begin to develop protocols for the use of ECMO, it is important to note select conditions when this therapy is unlikely to be succesful.
  • Chronic respiratory or cardiac disease with no hope of recovery
  • OHCA with prolonged no blood flow
  • Severe aortic regurgitation
  • Type A aortic dissection
  • Refractoroy septic shock with preserved LV function
  • Stem cell transplant patients
  • Advanced age with ARDS
  • Prolonged pre-ECMO mechanical ventilation (> 7 days)
  • Center inexperienced with ECMO

Show References

Can NIV be Used in ARDS?

• Mechanical ventilation can cause lung injury and increase patient morbidity and mortality.
• Noninvasive ventilation (NIV) is well-known to decrease intubation rates and improve patient outcome in select disease states (i.e., COPD, acute CHF).
• For patients with acute respiratory distress syndrome (ARDS), NIV may reduce the work of breathing by opening collapsed alveoli, increasing FRC, and improving oxygenation.
• To date, there are only a few RCTs that have evaluated the use of NIV in ARDS.
• Unfortunately, these trials have failed to demonstrate improved patient outcome or decreased intubation rates in patients with ARDS.
• Clinical Bottom Line: Intubate patients with ARDS who are difficult to oxygenate with standard oxygen therapy.

Show References

Cerebral Venous Thrombosis

• Approximately 25% of patients with cerebral venous thrombosis (CVT) will experience neurologic deterioration.
• This is most commonly due to an increase in ICP that results in transtentorial herniation.
• While heparin remains the treatment of choice for CVT, consider the following alternative strategies in the acutely decompensating patient:
  • Endovascular thrombolysis
  • Mechanical thrombectomy
  • Decompressive hemicraniectomy

Show References

Sepsis-3

• After nearly 2 decades, the definitions for sepsis and septic shock have been updated.
• Key findings from the Task Force convened by SCCM and ESICM include:
  • Sepsis
    • Definition: life-threatening organ dysfunction due to a dysregulated host response to infection
    • ICU patients: organ dysfunction is defined as an increase of 2 points or more in the Sequential Organ Failure Assessment (SOFA) score
    • ED patients: 2 or more of the following new qSOFA (quickSOFA) score may identify patients with increased mortality
      • SBP less than or equal to 100 mm Hg
      • RR greater than or equal to 22
      • Altered mental status
  • Septic Shock
    • Definition: a subset of patients with sepsis and profound circulatory, cellular, and metabolic abnormalities
    • Clinical Criteria:
      • Persistent hypotension requiring vasopressors to maintain MAP greater than or equal to 65 mm Hg despite adequate volume resuscitation
      • Lactate greater than or equal to 2 mmol/L
  • The term "severe sepsis" is no longer used

Show References

Shock Index

• The shock index (SI) is calculated as the ratio of heart rate to systolic blood pressure and is often used in the assessment of critically ill patients.
• A SI > 0.8 has been shown to be an independent predictor of post-intubation hypotension during emergency airway management.
• Kristensen and colleagues performed a retrospective review in a single-center in Denmark to evaluate the ability of SI to predict 30-day mortality.
• In over 110,000 patients, they found a weaker association of SI with 30-day mortality in patients > 65 years of age, those taking a beta-blocker or calcium channel blocker, or those with a history of hypertension.
• Notwithstanding, a SI > 1 was a significant predictor of mortality across all patient populations and should be considered a warning of serious illness.

Show References

Acute Chest Syndrome

• Acute chest syndrome (ACS) accounts for the most common cause of ICU admission and the most common cause of death in sickle cell patients.
• Important pearls for ACS include:
  • Chlamydophila pneumonia is the most common bacterial cause of ACS in adults, whereas Mycoplasma pneumonia is the most common bacterial cause in children.
  • CXR abnormalities may be absent early in disease.
  • Children are more likely to have middle lobe disease, in contrast to adults who often have lower lobe involvement.
  • Acute RV failure is a well recognized complication of ACS - use ultrasound to evaluate the RV and be careful with fluids.

Show References

Mechanical Ventilation for Septic Patients in Resource-Limited Settings

• An international team of physicians just published a series of recommendations for ventilatory support of septic patients in resource-limited settings.
• Pearls from these recommendations include:
  • Elevate the head of the bed to 30^o - 45^o
  • Consider tidal volumes of 5 - 7 ml/kg PBW in all patients
  • Use minimum levels of PEEP ( 5 cm H₂O) in all patients with sepsis and acute respiratory failure (unless the patient has moderate to severe ARDS)
  • Lower F_iO₂ to target SpO₂ > 88% or PaO₂ > 60 mm Hg
  • Use lung ultrasound to evaluate pulmonary edema when CXR is not available
  • Consider using SpO₂ to FiO₂ (S/F) as an alternative to P/F when blood gas analyzers are not available

Show References

Pain Management in the Critically Ill Patient

• Pain is common, often underappreciated, and routinely undertreated in our critically ill patients.
• Poorly treated pain has been shown to adversely affect both short- and long-term outcomes.
• Key pearls when treating pain in the critically ill:
  • Vital signs should not be used in isolation to assess pain
  • Use a validated assessment tool to objectively quantify pain (i.e., Critical Care Pain Observation Tool)
  • An analgosedation strategy (analgesics before sedative medications) has been shown to decrease duration of mechanical ventilation and decrease ICU LOS
  • Opioids have no maximum or ceiling dose. The appropriate dose is that which controls pain with the fewest side effects.

Show References

Hyperoxia in the Critically Ill

• Oxygen is liberally administered to many critically ill patients, thereby exposing them to supranormal arterial oxygen levels.
• Hyperoxia results in the formation of reactive oxygen species, which adversely affect the pulmonary, vascular, cnetral nervous, and immune systems.
• Though the optimal P_aO₂ remains unknown, recent evidence indicates that hyperoxia is associated with increased mortality in post-cardiac arrest, CVA, acute coronary syndrome, and traumatic brain injury patients.
• Take Home Point: Carefully titrate oxygen to the lowest tolerable level to meet the patient's needs.

Show References

Is It Really ARDS?

• Recent literature suggests that the incidence of ARDS in intubated ED patients may be as high as 10%.
• The Berlin Definition of ARDS includes the acute onset of bliateral opacities (CXR or chest CT) that is not fully explained by pulmonary edema or fluid overload.
• Emergency physicians and Intensivists are well versed in lung-protective ventilator settings for patients with ARDS.
• However, several diseases can appear simliar to ARDS and may require different ventilator strategies and treatments.
• In the absence of clinical risk factors for ARDS (e.g., sepsis, trauma), consider the following in your differential:
  • Idiopathic pulmonary fibrosis
  • Interstitial pneumonitis
  • Granulomatosis with polyangitis (Wegener's)
  • Diffuse alveolar hemorrhage
  • Goodpasture's syndrome

Show References

Blood Pressure Management in Severe Preeclampsia

• Severe preeclampsia (preeclampsia + at least one severe complication) accounts for almost 40% of deaths in obstetrical ICU admissions.
• Systolic arterial hypertension is the most important predictor of morbidity in patients with severe preeclampsia.
• First-line agents to reduce blood pressure in severe preeclampsia are nicardipine and labetalol.
• Hydralazine is no longer recommended as first-line therapy.
• Magnesium is used as an anticonvulsant and should not be considered an antihypertensive.

Show References